BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

395 related articles for article (PubMed ID: 24169734)

  • 1. Novel platinum(II) compounds with O,S bidentate ligands: synthesis, characterization, antiproliferative properties and biomolecular interactions.
    Mügge C; Liu R; Görls H; Gabbiani C; Michelucci E; Rüdiger N; Clement JH; Messori L; Weigand W
    Dalton Trans; 2014 Feb; 43(8):3072-86. PubMed ID: 24169734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum(II) Complexes with O,S Bidentate Ligands: Biophysical Characterization, Antiproliferative Activity, and Crystallographic Evidence of Protein Binding.
    Mügge C; Marzo T; Massai L; Hildebrandt J; Ferraro G; Rivera-Fuentes P; Metzler-Nolte N; Merlino A; Messori L; Weigand W
    Inorg Chem; 2015 Sep; 54(17):8560-70. PubMed ID: 26280387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Structure, solution chemistry, antiproliferative actions and protein binding properties of non-conventional platinum(II) compounds with sulfur and phosphorus donors.
    Mügge C; Rothenburger C; Beyer A; Görls H; Gabbiani C; Casini A; Michelucci E; Landini I; Nobili S; Mini E; Messori L; Weigand W
    Dalton Trans; 2011 Mar; 40(9):2006-16. PubMed ID: 21212880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis, structural characterization and cell death-inducing effect of novel palladium(II) and platinum(II) saccharinate complexes with 2-(hydroxymethyl)pyridine and 2-(2-hydroxyethyl)pyridine on cancer cells in vitro.
    Ari F; Aztopal N; Icsel C; Yilmaz VT; Guney E; Buyukgungor O; Ulukaya E
    Bioorg Med Chem; 2013 Nov; 21(21):6427-34. PubMed ID: 24054490
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, structural characterization, and pro-apoptotic activity of 1-indanone thiosemicarbazone platinum(II) and palladium(II) complexes: potential as antileukemic agents.
    Gómez N; Santos D; Vázquez R; Suescun L; Mombrú A; Vermeulen M; Finkielsztein L; Shayo C; Moglioni A; Gambino D; Davio C
    ChemMedChem; 2011 Aug; 6(8):1485-94. PubMed ID: 21608131
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, Spectroscopic Properties, Crystal Structure And Biological Evaluation of New Platinum Complexes with 5-methyl-5-(2-thiomethyl)ethyl Hydantoin.
    Bakalova AG; Buyukliev RT; Nikolova RP; Shivachev BL; Mihaylova RA; Konstantinov SM
    Anticancer Agents Med Chem; 2019; 19(10):1243-1252. PubMed ID: 30767754
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis, crystal structure, studies in solution and cytotoxicity of two new fluorescent platinum(II) compounds containing anthracene derivatives as a carrier ligand.
    Marqués-Gallego P; den Dulk H; Brouwer J; Kooijman H; Spek AL; Roubeau O; Teat SJ; Reedijk J
    Inorg Chem; 2008 Dec; 47(23):11171-9. PubMed ID: 18975941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel bis(thiosemicarbazones) of the 3,5-diacetyl-1,2,4-triazol series and their platinum(II) complexes: chemistry, antiproliferative activity and preliminary nephrotoxicity studies.
    Matesanz AI; Hernández C; Rodríguez A; Souza P
    Dalton Trans; 2011 Jun; 40(21):5738-45. PubMed ID: 21519595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modulation of drug activation profiles through carboxylate ligand modification in cytotoxic trans-platinum planar amine compounds.
    Benedetti BT; Quintal S; Farrell NP
    Dalton Trans; 2011 Nov; 40(41):10983-8. PubMed ID: 21918760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platinum(II) and palladium(II) complexes with (N,N') and (C,N,N')- ligands derived from pyrazole as anticancer and antimalarial agents: synthesis, characterization and in vitro activities.
    Quirante J; Ruiz D; Gonzalez A; López C; Cascante M; Cortés R; Messeguer R; Calvis C; Baldomà L; Pascual A; Guérardel Y; Pradines B; Font-Bardía M; Calvet T; Biot C
    J Inorg Biochem; 2011 Dec; 105(12):1720-8. PubMed ID: 22104300
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthesis, spectroscopic and DFT structural characterization of two novel ruthenium(III) oxicam complexes. In vivo evaluation of anti-inflammatory and gastric damaging activities.
    Tamasi G; Bernini C; Corbini G; Owens NF; Messori L; Scaletti F; Massai L; Giudice PL; Cini R
    J Inorg Biochem; 2014 May; 134():25-35. PubMed ID: 24518539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Palladium(II) and platinum(II) bis(thiosemicarbazone) complexes of the 2,6-diacetylpyridine series with high cytotoxic activity in cisplatin resistant A2780cisR tumor cells and reduced toxicity.
    Matesanz AI; Leitao I; Souza P
    J Inorg Biochem; 2013 Aug; 125():26-31. PubMed ID: 23685347
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on potential antitumor mechanism of a novel Schiff base copper(II) complex: synthesis, crystal structure, DNA binding, cytotoxicity and apoptosis induction activity.
    Qiao X; Ma ZY; Xie CZ; Xue F; Zhang YW; Xu JY; Qiang ZY; Lou JS; Chen GJ; Yan SP
    J Inorg Biochem; 2011 May; 105(5):728-37. PubMed ID: 21463568
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antitumor effects of a tetradentate amido-carboxylate ligands and corresponding square-planar palladium(II) complexes toward some cancer cells. Crystal structure, DFT modeling and ligand to DNA probe docking simulation.
    Matović ZD; Mrkalić E; Bogdanović G; Kojić V; Meetsma A; Jelić R
    J Inorg Biochem; 2013 Apr; 121():134-44. PubMed ID: 23376555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and in vitro anticancer activity of octahedral platinum(IV) complexes with cyclohexyl-functionalized ethylenediamine-N,N'-diacetate-type ligands.
    Lazić JM; Vucićević L; Grgurić-Sipka S; Janjetović K; Kaluderović GN; Misirkić M; Gruden-Pavlović M; Popadić D; Paschke R; Trajković V; Sabo TJ
    ChemMedChem; 2010 Jun; 5(6):881-9. PubMed ID: 20408161
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemistry and biology of two novel gold(I) carbene complexes as prospective anticancer agents.
    Messori L; Marchetti L; Massai L; Scaletti F; Guerri A; Landini I; Nobili S; Perrone G; Mini E; Leoni P; Pasquali M; Gabbiani C
    Inorg Chem; 2014 Mar; 53(5):2396-403. PubMed ID: 24547701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pt(II) complexes with bidentate and tridentate pyrazolyl-containing chelators: synthesis, structural characterization and biological studies.
    Francisco C; Gama S; Mendes F; Marques F; dos Santos IC; Paulo A; Santos I; Coimbra J; Gabano E; Ravera M
    Dalton Trans; 2011 Jun; 40(21):5781-92. PubMed ID: 21512700
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, characterization and biological activity of new cyclometallated platinum(iv) iodido complexes.
    Bauer E; Domingo X; Balcells C; Polat IH; Crespo M; Quirante J; Badía J; Baldomà L; Font-Bardia M; Cascante M
    Dalton Trans; 2017 Nov; 46(43):14973-14987. PubMed ID: 29048088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reactions with Proteins of Three Novel Anticancer Platinum(II) Complexes Bearing N-Heterocyclic Ligands.
    Sacco F; Tarchi M; Ferraro G; Merlino A; Facchetti G; Rimoldi I; Messori L; Massai L
    Int J Mol Sci; 2021 Sep; 22(19):. PubMed ID: 34638887
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rational design of dicarboxylato platinum(II) complexes with purine-mimetic ligands as novel anticancer agents.
    Hoffmann K; Wiśniewska J; Wojtczak A; Sitkowski J; Denslow A; Wietrzyk J; Jakubowski M; Łakomska I
    J Inorg Biochem; 2017 Jul; 172():34-45. PubMed ID: 28477537
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.